VKTX
Viking Therapeutics Inc
27.70$
-2.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.4% | +0.0% | +1.4% | +16.0% | +26.4% | +0.9% | -5,133.3% | – | -17.5% | -9.6% | +84.7% | – | |
| – | -8.9% | +95.6% | -11.3% | +26.8% | -36.9% | +100.2% | +19.4% | -45.8% | +17.1% | +20.4% | +7.7% | – | |
| – | +276.4% | +191.2% | -150.2% | – | – | -713.3% | – | -220.0% | – | -46.2% | -121.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -1,386.7% | -72.6% | – | -74.6% | +860.6% | -32.8% | +276.5% | -52.7% | -28.3% | +101.9% | – | |
| – | – | -102.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | +322,260.1% | -99.5% | -13.2% | -60.3% | -65.1% | +45.3% | -5.3% | +15,546.5% | -83.9% | +95.3% | – | |
| – | – | +664.1% | -208.3% | – | -468.0% | – | -136.0% | – | -1.6% | -172.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.